← Browse by Condition
Medical Condition
stage iva lung cancer ajcc v8
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2, Phase 1, EARLY_Phase 1
NCT03582124 Phase 1, Phase 2
Recruiting
Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery
Enrollment
30 pts
Location
United States
Sponsor
Stanford University
NCT04762199 Phase 1
Recruiting
MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer
Enrollment
69 pts
Location
United States
Sponsor
Emory University
NCT05493566 EARLY_Phase 1
Recruiting
Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer
Enrollment
15 pts
Location
United States
Sponsor
Emory University